Immunotherapy approaches targeting regulatory T-cells

Hideya Onishi, Takashi Morisaki, Mitsuo Katano

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

Original languageEnglish
Pages (from-to)997-1003
Number of pages7
JournalAnticancer research
Volume32
Issue number3
Publication statusPublished - Mar 1 2012

Fingerprint

Regulatory T-Lymphocytes
Immunotherapy
Immune System
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Onishi, H., Morisaki, T., & Katano, M. (2012). Immunotherapy approaches targeting regulatory T-cells. Anticancer research, 32(3), 997-1003.

Immunotherapy approaches targeting regulatory T-cells. / Onishi, Hideya; Morisaki, Takashi; Katano, Mitsuo.

In: Anticancer research, Vol. 32, No. 3, 01.03.2012, p. 997-1003.

Research output: Contribution to journalReview article

Onishi, H, Morisaki, T & Katano, M 2012, 'Immunotherapy approaches targeting regulatory T-cells', Anticancer research, vol. 32, no. 3, pp. 997-1003.
Onishi H, Morisaki T, Katano M. Immunotherapy approaches targeting regulatory T-cells. Anticancer research. 2012 Mar 1;32(3):997-1003.
Onishi, Hideya ; Morisaki, Takashi ; Katano, Mitsuo. / Immunotherapy approaches targeting regulatory T-cells. In: Anticancer research. 2012 ; Vol. 32, No. 3. pp. 997-1003.
@article{b3a4118df84c4b838129607c9b8628c8,
title = "Immunotherapy approaches targeting regulatory T-cells",
abstract = "The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.",
author = "Hideya Onishi and Takashi Morisaki and Mitsuo Katano",
year = "2012",
month = "3",
day = "1",
language = "English",
volume = "32",
pages = "997--1003",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Immunotherapy approaches targeting regulatory T-cells

AU - Onishi, Hideya

AU - Morisaki, Takashi

AU - Katano, Mitsuo

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

AB - The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

UR - http://www.scopus.com/inward/record.url?scp=84858771966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858771966&partnerID=8YFLogxK

M3 - Review article

C2 - 22399623

AN - SCOPUS:84858771966

VL - 32

SP - 997

EP - 1003

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -